G&S Capital LLC Teva Pharmaceutical Industries LTD Transaction History

G&S Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 24, 2020	SELL	$8.12 - $13.12 $56,929 - $91,984	-7,011 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$6.53 - $10.72 $6,523 - $10,709	999 Added 16.62%	7,011 $68,000
Q3 2019 Oct 17, 2019	BUY	$6.16 - $9.6 $12,320 - $19,200	2,000 Added 49.85%	6,012 $41,000
Q2 2019 Jul 19, 2019	BUY	$8.12 - $15.72 $16,239 - $31,440	2,000 Added 99.4%	4,012 $37,000
Q1 2018 Apr 25, 2018	BUY	$16.68 - $22.07 $6,672 - $8,828	400 Added 24.81%	2,012 $34,000
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $18,102 - $30,789	1,612	1,612 $31,000

604

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

Stay updated on G&S Capital LLC with notifications on news.